Two companies will be in the next Monday Yi Sheng Pharmaceutical industry two years ago was not again again

China Securities Regulatory Commission issued a 18th announcement that the Commission will be held on February 21, 2011 in 2011, the 25th and 27th Audit Committee working meeting, respectively, Jilin ji Yi Sheng Pharmaceutical Co., Ltd. and Deloitte Group Co., Ltd. starting application. Jilin Province ji ' an Yi Sheng Pharmaceutical Co., Ltd. is not the first time. At the Commission's meeting on December 11, 2009, the initial application of the company was not made.　　It has also become the only company in the pharmaceutical industry that has been in the 2009 SME IPO. Jilin ji ' an Yi Sheng Pharmaceutical Co., Ltd. the proposed issue of 27.6 million shares, after the issuance of the company's total share capital of 110.3172 million shares. The company is mainly engaged in research and development of proprietary Chinese medicine, production and sales, the scope of treatment of products to cardiovascular and cerebrovascular diseases. Company leading products include Shengmai injection, vibration source capsules and qingkailing injection, 2008, 2009 and 2010, the total sales revenue of the three products accounted for the current main business income of 82.85%, 84.17% and 86.54%　　The total sales margin accounted for 83%, 86.28% and 87.77% of the company's gross profit margin for the same period. Deloitte Group Co., Ltd. this time the proposed issue does not exceed 68 million shares, the total share capital after the issue does not exceed 268 million shares. The company is mainly engaged in domestic coastal and inland river dry bulk cargo transport, mainly coal transportation. 2008, 2009 and 2010 the company's main business income annual composite growth rate of 68.6%; 2008, 2009 and 2010 the net profit growth rate of the company attributable to the parent company's shareholder is 49.15%. (Securities Times reporter Zheng)